“…For instance, in 2006 the US health care system used usage rates for plasma products. For instance, in 2006 the US health care system used 105 grams per/1,000 people of the dominant plasma product (immunoglobulin) 105 grams per/1,000 people of the dominant plasma product (immunoglobulin) which was more than 250 percent of the rate in Italy, the United Kingdom, Germany, which was more than 250 percent of the rate in Italy, the United Kingdom, Germany, the Netherlands, and Japan (Flood et al 2006), suggesting that the noncompensated the Netherlands, and Japan (Flood et al 2006), suggesting that the noncompensated plasma collection system might be limiting potential usage in many countries. plasma collection system might be limiting potential usage in many countries.…”